Medical research

Researchers discover why drug for severe COPD becomes less effective

Roflumilast, a drug recently approved in the United States to treat severe chronic obstructive pulmonary disease (COPD), increases the production of a protein that causes inflammation, which possibly results in patients developing ...

Inflammatory disorders

Understanding the genetics of inflammation

The Kennedy Institute of Rheumatology is an international centre of excellence for researching inflammation in the body, from causes to treatments. Professor Irina Udalova is the Institute's principal investigator of the ...

Surgery

Delays in gallstone pancreatitis surgery increase risks

The recommended treatment for mild gallstone pancreatitis in patients aged over 50 years is laparoscopic cholecystectomy, yet over half of New South Wales patients presenting with the condition did not undergo the surgery ...

page 19 from 40